Source: International Congress 2018 – What is new in idiopathic interstitial pneumonias?
Disease area: Interstitial lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
S. Kronborg-White (Aarhus, Denmark), C. Uggerhøj Andersen (Aalborg, Denmark), O. Hilberg (Vejle, Denmark), E. Bendstrup (Aarhus, Denmark). Safety in treating dyspnea with morphine in ILD patients. 5241

Member's Comments

No comment yet.

Related content which might interest you: Respiratory depression secondary to morphine use in a patient with COPD and refractory breathlessness Source: Eur Respir J, 49 (5) 1601858; 10.1183/13993003.01858-2016 Year: 2017 Utility of palliative treatment of dyspnoea with epidural methadone in patients with advanced emphysema Source: Eur Respir J 2001; 18: Suppl. 33, 58s Year: 2001 Impact of nebulized fentanyl on exertional dyspnea in interstitial lung disease Source: International Congress 2019 – Exploring exercise responses in respiratory diseases Year: 2019 Sertraline effects on dyspnea in patients with severe COPD Source: Eur Respir J 2005; 26: Suppl. 49, 288s Year: 2005 Attitudes of patients with chronic breathlessness towards treatment with opioids Source: Eur Respir J, 55 (2) 1901752; 10.1183/13993003.01752-2019 Year: 2020 Fentanyl nasal spray in a patient with end-stage COPD and severe chronic breathlessness Source: Breathe, 15 (3) e122; 10.1183/20734735.0183-2019 Year: 2019 Survey of dyspnoea in COPD patients on medication and preemptive use of a short-acting β-2 agonist Source: Annual Congress 2009 - Drug effects in COPD Year: 2009 Management of refractory dyspnoea in COPD Source: Virtual Congress 2021 – Highlights from the JAMA Network on idiopathic pulmonary fibrosis, chronic obstructive pulmonary disease and lung cancer screening Year: 2021 Safety of once-daily QMF149 in patients with persistent asthma Source: Annual Congress 2012 - Asthma treatment: efficacy and safety Year: 2012 Opioid prescription for severe chronic breathlessness to hospitalised patients with COPD - a clinical audit Source: Virtual Congress 2020 – Clinical data and COPD management Year: 2020 Pretreatment with inhaled procaterol improves symptoms of dyspnea and quality of life in patients with severe COPD Source: Annual Congress 2012 - COPD treatments: efficacy and safety Year: 2012 Are COPD patients with chronic dyspnea and attending pulmonary rehabilitation treated with dual bronchodilatation or not? Source: International Congress 2016 – Best abstracts in COPD management Year: 2016 Is nebulized morphine effective in treating persistent dyspnea in very severe COPD? A preliminary report Source: International Congress 2015 – Latest insights into the management of chronic respiratory diseases Year: 2015 Use of inhaled corticosteroids and the risk of depressive symptoms in patients with chronic obstructive pulmonary disease Source: Virtual Congress 2021 – Lung disease burden and management Year: 2021 Efficacy and safety of intravenous montelukast in patients with acute exacerbations of bronchial asthma Source: Annual Congress 2008 - Recent advances in the treatment and pathogenesis of asthma Year: 2008 Mechanisms of dyspnoea relief following radiation treatment in a patient with severe COPD Source: Eur Respir J 2011; 38: 728-730 Year: 2011 Use of bisoprolol: comparison of symptoms worsening in patients with asthma and COPD Source: Annual Congress 2008 - Recent advances in the treatment and pathogenesis of pulmonary diseases Year: 2008 Cardio- and cerebrovascular safety of QVA149 in patients with moderate-to-severe COPD: A pooled analysis Source: International Congress 2014 – Clinical trials of drugs and biomarkers for respiratory diseases Year: 2014 Safety of once-daily glycopyrronium in patients with severe-to-very severe COPD: The SPARK study Source: Annual Congress 2013 –New clinical trials of asthma and COPD drugs Year: 2013 Morning and nighttime symptoms in COPD and efficacy of aclidinium/formoterol in symptomatic vs asymptomatic patients Source: International Congress 2015 – Notable abstracts in COPD: variety Year: 2015